1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Non-Invasive Aesthetic Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Non-Invasive Aesthetic Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Non-Invasive Aesthetic Treatment Market Regional Analysis
6.2 Asia Pacific Non-Invasive Aesthetic Treatment Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Non-Invasive Aesthetic Treatment Market Forecast Analysis
7. Asia Pacific Non-Invasive Aesthetic Treatment Market Analysis – by Procedure
7.1 Injectables
- 7.1.1 Overview
- 7.1.2 Injectables: Asia Pacific Non-Invasive Aesthetic Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Skin Rejuvenation
- 7.2.1 Overview
- 7.2.2 Skin Rejuvenation: Asia Pacific Non-Invasive Aesthetic Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Asia Pacific Non-Invasive Aesthetic Treatment Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Asia Pacific Non-Invasive Aesthetic Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Clinics and Medical Spas
- 8.2.1 Overview
- 8.2.2 Clinics and Medical Spas: Asia Pacific Non-Invasive Aesthetic Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Asia Pacific Non-Invasive Aesthetic Treatment Market – Asia-Pacific Analysis
9.1 Overview
9.2 Asia-Pacific
- 9.2.1 Asia Pacific Non-Invasive Aesthetic Treatment Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 Asia Pacific Non-Invasive Aesthetic Treatment Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 China:
Asia Pacific Non-Invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 China: Asia Pacific Non-Invasive Aesthetic Treatment Market Breakdown, by Procedure
- 9.2.1.1.2 China: Asia Pacific Non-Invasive Aesthetic Treatment Market Breakdown, by End User
- 9.2.1.2 India:
Asia Pacific Non-Invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 India: Asia Pacific Non-Invasive Aesthetic Treatment Market Breakdown, by Procedure
- 9.2.1.2.2 India: Asia Pacific Non-Invasive Aesthetic Treatment Market Breakdown, by End User
- 9.2.1.3 Japan:
Asia Pacific Non-Invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Japan: Asia Pacific Non-Invasive Aesthetic Treatment Market Breakdown, by Procedure
- 9.2.1.3.2 Japan: Asia Pacific Non-Invasive Aesthetic Treatment Market Breakdown, by End User
- 9.2.1.4 Australia:
Asia Pacific Non-Invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Australia: Asia Pacific Non-Invasive Aesthetic Treatment Market Breakdown, by Procedure
- 9.2.1.4.2 Australia: Asia Pacific Non-Invasive Aesthetic Treatment Market Breakdown, by End User
- 9.2.1.5 Rest of Asia-Pacific :
Asia Pacific Non-Invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Non-Invasive Aesthetic Treatment Market Breakdown, by Procedure
- 9.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Non-Invasive Aesthetic Treatment Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Galderma
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Alma Lasers
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Merz Pharma
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Bausch Health Companies Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Cutera Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 AbbVie Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Candela Medical
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Johnson and Johnson Services, Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations